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Abstract
Background: The association between sensitizations and severity of allergic diseases is controversial.
Objective: This study was to investigate the association between severity of asthma and rhinitis and degree of
specific allergic sensitization in allergic patients in China.
Method: A cross-sectional survey was performed in 6304 patients with asthma and/or rhinitis from 4 regions of
China. Patients completed a standardized questionnaire documenting their respiratory and allergic symptoms, their
impact on sleep, daily activities, school and work. They also underwent skin prick tests with 13 common
aeroallergens. Among the recruited subjects, 2268 provided blood samples for serum measurement of specific IgE
(sIgE) against 16 common aeroallergens.
Results: Significantly higher percentage of patients with moderate-severe intermittent rhinitis were sensitized to
outdoor allergens while percentage of patients sensitized to indoor allergens was increased with increasing severity
of asthma. Moderate-severe intermittent rhinitis was associated with the skin wheal size and the level of sIgE to
Artemisia vulgaris and Ambrosia artemisifolia (p < 0.001). Moderate-severe asthma was associated with increasing
wheal size and sIgE response to Dermatophagoides (D.) pteronyssinus and D. farinae (p < 0.001). Moderate-severe
rhinitis and asthma were also associated with increase in number of positive skin prick test and sIgE.
Conclusions: Artemisia vulgaris and Ambrosia artemisifolia sensitizations are associated with the severity of
intermittent rhinitis and D. pteronyssinus and D. farinae sensitizations are associated with increasing severity of
asthma in China. Increase in number of allergens the patients are sensitized to may also increase the severity of
rhinitis and asthma.
Keywords: sensitization, aeroallergens, disease severity, allergic rhinitis, asthma, association.
Background
The prevalence of asthma and allergic rhinitis symptoms
varies considerably across the world [1,2]. In China, the
prevalence of allergic rhinoconjunctivitis symptoms varies
from 8.7 to 24.1% documented by self-reported telephone
interviews conducted between 2004 and 2005 in 11 cities
[3]. The prevalence of respiratory allergy is increasing in
China [3,4] and an international comparative study found
that in the city of Guangzhou, the prevalence of asthma
symptoms among children aged 13-14 years increased
from 3.4% in 1995 to 4.8% in 2001 [4] and to 6.1% in 2009
(unpublished data).
Atopic sensitization is a risk factor for the development
of upper and lower respiratory symptoms [5,6]. Exposure
to allergens the patients are sensitized to may exacerbate
symptoms of rhinitis and asthma by promoting airway
inflammation, airflow limitation, and airway hyperrepon-
siveness (AHR). Sensitization to indoor allergens corre-
lates well with indoor allergen exposure in pre-school
and school-age children [7,8]. Furthermore, exposure and
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Evidence supporting this relationship is particularly
strong for house dust mite (HDM) sensitization [9].
Allergic rhinitis can also be caused by pollens from
grasses and trees which are the most important sources
of outdoor sensitizing allergens [10,11]. We have pre-
viously performed an epidemiological study of the preva-
lence of sensitization in patients with asthma and/or
rhinitis in mainland China [12]. For indoor and outdoor
allergens, we found that house dust mite sensitization
was consistently associated with asthma whereas Artemi-
sia vulgaris and Ambrosia artemisifolia pollen sensiti-
zaions were associated with the development of rhinitis
[12].
Both rhinitis and asthma are diseases of variable sever-
ity. Many studies have shown that the degree of allergic
sensitivity as reflected by elevated serum allergen-speci-
fic IgE levels or allergen skin wheal size is related to
asthma severity [13,14], however, other studies [15,16]
did not find this relationship.
Thus, the influence of the degree of allergic sensitivity
on the disease severity of allergic asthma and rhinitis
remains uncertain. The aim of this study was to investigate
the relationship between size of skin test or level of serum
specific IgE and the severity of asthma and rhinitis in Chi-
nese patients based on data from a recently conducted
nation-wide multicentre epidemiology study.
Methods
Study population and definitions
The study was a cross-sectional epidemiologic survey, con-
ducted from February 2006 to March 2007 in 17 cities
with 24 participating centers from northern, eastern, south
western and southern coastal regions of China. The study
covered mid-temperate, warm-temperate, subtropical and
tropical zones of China. Patients aged 5 to 65 years attend-
ing outpatient clinics at 24 centers, and diagnosed as rhini-
tis and/or asthma, were invited to participate in this
survey. By evaluating their history, questionnaire and rele-
vant tests, rhinitis was defined as having symptoms of
sneezing, or a running, itchy or blocked nose when the
patient did not have a cold or flu. Asthma was defined by
a history of recurrent dyspnea, wheezing or cough epi-
sodes, positive airway reversibility testing (FEV1 increasing
≥12% and 200 ml after inhalation of 400 mg of salbuta-
mol) or positive airway responsiveness testing (FEV1
decreasing ≥20% when ≤ 7.8 μmol of cumulative dose of
histamine is administered). The study was approved by the
Ethics Review Board of each study center and all patients
gave written consent before the study.
Questionnaire
The standardized questionnaire was administered by the
trained physicians or research nurses face-to-face with
questions regarding demographic characteristics, family
history of allergic diseases, symptoms of rhinitis, wheez-
ing or coughing, eczema and burning or itchy eyes,
smoking habits, environmental exposure factors, animal
pet ownership and dietary habits. Questions about
impact of allergic symptoms on daily activities, work or
school, night-time sleep, and use of medications for
controlling the symptoms were also documented.
Assessment of severity of rhinitis and asthma
According to the Allergic Rhinitis and its Impact on
Asthma guidelines [17], rhinitis was classified as “mild”
and “moderate/severe” depending on the severity of
symptoms and their impact on sleep, daily activities,
school and work evaluated by the questionnaire. Severity
of asthma was classified according to the 2006 version
of Global Initiative for Asthma guidelines [18].
Skin prick test (SPT)
The sensitivity to thirteen common aeroallergens was
tested including Dermatophagoides (D.) pteronyssinus,
D. farinae and Blomia tropicalis,d o g ,c a t ,Periplaneta
americana, Blatella germanica, Artemisia vulgaris, Ambro-
sia artemisifolia, mixed grass and tree pollen, mould mix I
and IV. Allergen extracts and control solutions were
obtained from ALK (Horsholm, Denmark). Histamine
(10 mg/ml) and diluent were used as positive and negative
controls. SPT was performed on the volar side of the fore-
arm. The wheal reaction after 15 minutes was measured
as the mean of the longest diameter and the length of the
perpendicular line through its middle. A positive skin
reaction was defined as a wheal size 3 mm greater than
the negative control. The result was also expressed as skin
index (SI = mean size of allergen wheal/mean size of hista-
mine wheal). Atopy was defined as the presence of at least
one positive skin reaction to any allergen tested.
We originally recruited 6411 questionnaires and 6393
skin test reports. Among the 6411 questionnaires, 107
were invalid for lacking proper diagnosis, incompletely
answering the questionnaire or missing skin test report.
Of the 6393 skin test reports, 89 were rejected for missing
questionnaire data, wrong codings, or missing the hista-
mine and normal saline readings. Hence, we restricted our
final valid data with 6304 patients.
Serum specific IgE Analysis
Among the 24 centers, 14 of them obtained serum sam-
ples from their subjects for sIgE analysis. With the writ-
ten consents, peripheral blood was obtained from
patients in the above centers only after completing the
questionnaires and skin prick tests. Finally, 2268 out of
t h e6 3 0 4p a t i e n t s( 8 0 6w i t h rhinitis alone, 773 with
asthma alone and 689 with both rhinitis and asthma)
from four regions provided blood for measurement of
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each subject was coagulated at room temperature, centri-
fuged, stored at -20°C. The sIgE against D. pteronyssinus,
D. farinae,c a t ,d o g ,Periplaneta americana, Blatella ger-
manica, Penicillium, Cladosporium, Fusarium, sycamore,
willow, cottonwood, elm, grass pollen, Artemisia vulgaris,
Ambrosia artemisifolia was measured with the ADVIA
Centaur
® immunoassay system (Bayer Healthcare LLC,
Tarrytown New York, USA) [19]. The analysis for sIgE
was defined to be positive if the measurement was
≥ 0.35 kU/L.
Quality control
Standardized protocol, questionnaire, allergen skin prick
testing set, and operating procedures were used by all the
centers. All questionnaire interviewers and performers of
skin prick testing were trained before the study. Results
of questionnaire and skin prick tests were sent every
month to Guangzhou, where the data were input and
analyzed. Quality control reports were then prepared for
each center. Each completed questionnaire and skin test
report was verified by the center supervisor and the
results were double-checked by the principal investigator
and fed back to each center. All questionnaires and skin
test data were coded and input into a programmed data-
base by two persons independently. The entered data
were checked for out-of-range values and logic mistakes.
Statistical analysis
For all analyses p < 0.05 was regarded as statistically sig-
nificant. Prevalences of sensitization to various groups of
allergens are presented. The differences of the sensitiza-
tion rate between different severities of rhinitis and
asthma were determined by chi-square tests. Skin prick
test mean wheal diameter were used as raw data. The
relationship between quantitative mean skin wheal dia-
meter and severity of rhinitis or asthma was analyzed
using logistic regression. Fitted predicted probability
curves of moderate-severe rhinitis and asthma according
to the wheal size of skin sensitizations were plotted using
the results from the logistic regression. For the quantita-
tive evaluations, the OR are presented for different skin
prick test mean wheal diameters expressing the increased
risk of severity of rhinitis and asthma associated with
increasing skin wheal size. For associations between sIgE
concentrations and different severities of rhinitis and
asthma, we calculated the prevalence of rhinitis and
asthma severities with different sIgE levels against D.
pteronyssinus, D. farinae, Artemisia vulgaris and Ambro-
sia artemisifolia sIgE and the statistical significance of
the differences were determined by using chi-square
tests. All data were categorized and analyzed using the
Statistical Package for the Social Sciences (SPSS Inc. Chi-
cago, IL, USA) for Windows Release 13.0 and Microcal
Origin 6.0 (Microcal Softwar eI n c . ,N o r t h a m p t o n ,M A ,
USA).
Results
Of the 6304 patients, 967 subjects had mild intermittent
rhinitis, 452 had moderate-severe intermittent rhinitis,
1729 had mild persistent rhinitis and 1154 had moderate-
severe persistent rhinitis. Asthma was under control in
741 patients while 441 patients had intermittent asthma
(step 1), 735 with mild persistent (step 2), 948 with moder-
ate persistent (step 3) and 915 with severe persistent
asthma (step 4). Patients with moderate-severe intermit-
tent rhinitis had significantly higher prevalence of sensiti-
zation to dogs, Artemisia vulgaris, Ambrosia artemisifolia,
mixed grass pollen and mixed tree pollen (p < 0.001) by
skin prick tests. They also showed significantly greater per-
centage of multiple sensitizations (p < 0.05). Prevalence of
sensitization to D. pteronyssinus, D. farinae, blomia tropi-
calis, dog and cat was increased with increasing of disease
severity in patients with asthma. Furthermore, with
increasing severity of asthma, there is higher proportion of
patients with multiple sensitizations (Table 1).
Serum specific IgE against 16 common aeroallergens
was measured in 2268 patients in whom 175 were classi-
fied as mild intermittent rhinitis, 281 as moderate-severe
intermittent rhinitis, 596 as mild persistent rhinitis and
339 as moderate-severe persistent rhinitis. For asthma
patients, 405 were at mild intermittent stage, 313 at mild
persistent, 335 at moderate persistent and 628 at severe
persistent stage. D. pteronyssinus and D. farinae were
found to be the most prevalent allergens followed by Arte-
misia vulgaris and Ambrosia artemisifolia with sIgE mea-
surements in patients with rhinitis and asthma.
Significantly higher percentage of patients with moderate-
severe intermittent rhinitis was sensitized to Artemisia
vulgaris (p < 0.001), Ambrosia artemisifolia (p < 0.001),
willow (p < 0.01), elm (p < 0.05) and grass pollen (p <
0.05). Elevated levels of sIgE against D. pteronyssinus and
D. farinae in patients with asthma were associated with
increasing the severity (p < 0.001). Multiple sensitizations
was significantly associated with increasing in level of
asthma severity (p < 0.001) (Table 2).
Allergen skin test sizes and severity of rhinitis and
asthma
Using allergen skin prick test wheal size as a continuous
variable, the risk of having moderate-severe rhinitis in
our patients was at around 40%-42.5% when they were
n o ts e n s i t i z e dt oArtemisia vulgaris (Figure 1A) or
Ambrosia artemisifolia (Figure 1B), or any tested allergen
(Figure 1C). But the risk increased significantly with
increasing skin wheal size to Artemisia vulgaris (OR 1.12,
95% CI 1.07-1.14, p < 0.001) and Ambrosia artemisifolia
(OR 1.19, 95% CI 1.13-1.41, p < 0.001) corresponding to
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23.71 at 20 mm, respectively (Figure 1A-1B). Similarly,
when patients were not sensitized to D. pteronyssinus
(Figure 1D) and D. farinae (Figure 1E), or to the tested
allergens (Figure 1F), the probability of having moderate-
severe asthma was at around 66%, but the risk increased
for 1.21-fold per mm increase in skin wheal size to D.
pteronyssinus and D. farinae (95% CI 1.09-1.46 and 1.10-
1.47 respectively, p < 0.001), corresponding to an OR of
1.84 and 1.74 at 10 mm wheal size, and 2.76 and 2.63 at
20 mm, respectively (Figure 1D-1E). In addition, moder-
ate-severe rhinitis and asthma were also associated
with increasing number of skin sensitized allergens
(Figure 1C, F).
Table 1 Prevalence (%) of allergen skin sensitizations in patients with rhinitis and asthma of different severity
Rhinitis Asthma
MI
(n = 967)
MSI
(n = 452)
MP
(n = 1729)
MSP
(n = 1154)
c2p M I
(n = 441)
MIP
(n = 735)
MOP
(n = 948)
SP
(n = 915)
c2p
D. pteronyssinus 61.1 59.7 61.8 60.9 7.0 0.092 51.7 58.5 62.0 64.5 34.6 0.000
D. farinae 62.1 60.6 64.3 63.1 3.16 0.371 52.6 60.2 63.7 65.6 36.5 0.000
Blomia tropicalis 43.3 43.3 44.4 44.9 0.6 0.901 32.3 39.0 44.4 48.4 56.7 0.000
Dog 15.9 20.1 14.0 16.5 13.8 0.003 12.4 13.2 14.3 18.0 17.2 0.001
Cat 9.8 13.1 10.5 10.1 5.03 0.17 8.7 11.7 12.9 13.6 11.0 0.012
American cockroach 15.3 16.7 16.9 17.2 0.88 0.83 15.8 17.4 16.6 19.4 5.8 0.12
Blatella germanica 10.7 13.7 12.8 13.0 2.53 0.47 9.9 10.6 13.3 13.2 8.2 0.042
Artemisia vulgaris 16.5 30.5 8.0 13.1 202.4 0.000 9.8 7.7 9.6 8.8 2.3 0.52
Ambrosia artemisifolia 10.9 20.1 3.9 6.9 167.7 0.000 5.2 4.7 5.2 4.1 2.5 0.483
1Mixed grass pollen 3.1 4.8 2.0 1.5 21.0 0.000 2.4 2.1 2.7 2.3 0.7 0.872
2Mixed tree pollen 4.6 8.2 2.2 3.8 45.5 0.000 4.9 2.1 3.2 3.9 7.7 0.053
3Mixed mould I 6.9 6.3 7.8 6.2 7.6 0.07 6.2 7.7 8.1 8.2 2.9 0.409
4Mixed mould IV 5.4 5.0 5.9 4.1 6.0 0.13 4.8 4.2 6.0 5.5 2.9 0.404
≥2 sensitizations 72.6 74.3 68.5 69.5 9.548 0.023 59.4 65.3 70.3 71.1 34.24 0.000
1 Mixed grass pollen: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pretense and Poa pratensis;
2 Mixed tree pollen: Ulmus americana, Platanus
acerifolia, Salix caprea and Populus deltoids;
3 Mixed mould I: Alternaria alternata, Cladosporium herbarum, Fusarium sp and Chaetomium globosum;
4 Mixed
mould IV: Penicillium (P.) brevicompactum, P. expansum, P. notatum and P. roqueforthi. MI: mild intermittent; MSI: moderate-severe intermittent; MP: mild
persistent; MSP: moderate-severe persistent; MIP: mild persistent; MOP: moderate persistent; SP: severe persistent.
Table 2 Prevalence (%) of serum specific IgE positivity to tested allergens in patients with rhinitis and asthma of
different severity
Rhinitis Asthma
MII
(n = 175)
MSI
(n = 281)
MIP
(n = 596)
MSP
(n = 339)
c2 p MII
(n = 405)
MIP
(n = 313)
MOP
(n = 335)
SEP
(n = 628)
c2p
D. pteronyssinus 44.3 45.2 50.2 47.0 2.96 0.401 22.7 52.4 59.4 79.1 332.6 0.000
D. farinae 43.8 46.0 49.1 44.7 2.56 0.463 21.0 49.2 58.5 77.2 320.2 0.000
Cat 10.2 7.8 9.1 10.1 1.17 0.765 7.3 9.8 9.5 10.5 1.90 0.594
Dog 5.4 3.9 4.2 5.2 1.03 0.792 2.1 4.4 3.0 5.1 4.86 0.182
American cockroach 0 1.6 1.3 0.6 3.13 0.372 2.3 1.1 1.1 1.8 1.46 0.712
Blatella germanica 0 3.5 2.2 2.3 5.75 0.125 1.6 2.9 4.0 2.3 3.68 0.302
Penicillium 2.1 0.9 1.3 0.3 3.40 0.337 0 0.6 1.2 1.3 4.38 0.209
Cladosporium 0 0 0.2 0 1.26 0.741 0 0 0 0.3 1.62 0.795
Fusarium 29.1 28.2 23.9 24.2 2.29 0.515 17.9 22.6 25.7 22.7 2.534 0.470
Sycamore 5.1 5.6 2.1 3.3 7.57 0.060 2.3 2.2 1.8 2.7 0.741 0.867
Willow 3.8 6.8 2.0 4.0 11.9 0.008 1.7 1.6 2.9 2.9 1.773 0.642
Cottonwood 5.0 6.8 2.7 4.5 7.83 0.050 2.8 2.1 3.6 3.4 0.998 0.805
Elm 6.8 9.1 4.1 4.5 9.63 0.024 2.2 2.1 3.1 4.0 2.837 0.416
Grass pollen 4.3 4.4 1.3 2.8 8.87 0.030 1.1 0 1.9 2.1 4.55 0.212
Artemisia vulgaris 19.5 27.1 6.1 6.7 93.2 0.000 5.4 4.0 4.8 5.4 .747 0.870
Ambrosia artemisifolia 14.9 29.2 0.7 0.9 98.7 0.000 0 0 0.7 1.2 4.651 0.184
≥2 sensitizations 16.3 21.8 19.9 21.8 7.30 0.063 15.8 18.8 21.7 26.6 39.1 0.000
MII: Mild intermittent; MSI: Moderate-severe intermittent; MIP: Mild persistent; MSP: Moderate-severe persistent; MOP: Moderate persistent; SEP: Severe persistent
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Page 4 of 8Allergen sIgE levels and severity of asthma and rhinitis
Among patients with rhinitis, we found that significantly
higher percentage of patients with moderate-severe inter-
mittent rhinitis had higher level of sIgE to Artemisia vul-
garis and Ambrosia artemisifolia (p < 0.001) but not to D.
pteronyssinus and D. farinae (Figure 2). For asthma
patients, sIgE levels against D. pteronyssinus and D. fari-
nae, but not Artemisia vulgaris and Ambrosia artemisifo-
lia, were significantly associated with increasing of asthma
severity (p < 0.001) (Figure 3).
Discussion
In this nation-wide multicentre epidemiologic study of
more than 6300 asthmatic and rhinitis patients with vary-
ing disease severity in China, we found D. pteronyssinus
and D. farinae sensitizations were significantly associated
with severity of asthma while Artemisia vulgaris and
Ambrosia artemisifolia sensitizations were related to
severity of rhinitis. Furthermore, multiple allergen sensi-
tization was also associated with severity of rhinitis and
asthma as determined by either skin prick test or sIgE
measurements.
In this paper, our data show that severity of asthma
was significantly correlated with skin index of reactivity
to D. pteronyssinus, D. farinae and Blomia tropicalis.
F u r t h e r m o r e ,w ea l s of o u n dt h a te l e v a t e dl e v e l so fs I g E
to D. pteronyssinus and D. farinae correlate significantly
with increasing severity of asthma. Our findings support
the concept that sensitization against indoor allergens
may affect asthma severity [13,20]. Allergens induce sen-
sitizations in persons who are in high risk and repetitive
exposure to the allergens may lead to allergic inflamma-
tory reactions in the airway mucosa [21]. Airway inflam-
mation may be variably associated with changes in
airway hyperresponsiveness, airflow limitation, respira-
tory symptoms, and disease chronicity [22]. Our finding
that patients who had HDM sensitization were more
likely to have more severe asthma, compared to those
without sensitization, is consistent with many other stu-
dies in children or adults [23]. Platts-Mills et al. [24]
reported that load of house dust mites is associated with
the onset of respiratory allergic conditions, especially
bronchial asthma, and that there exists a threshold of
HDM exposure to induce symptoms of asthma. Even
exposure to low levels of mite allergens (0.02-2.0 μg/g
dust) was found to be a significant risk factor for sensiti-
zation [25]. A few studies found several species of HDM
in indoor environment in China [26,27] and relatively
high levels of HDM group 1 allergens (> 10 μg/g dust)
has been detected in a very high proportion of dust
samples from southern China [28].
Not surprisingly, we demonstrated quantitative asso-
ciation between the size of skin test and the specific IgE
levels to pollens especially Artemisia vulgaris and
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Figure 1 Skin allergen sensitization and severity of rhinitis and asthma. (A-F) Fitted predicted probability curves (and 95% CI) for moderate-
severe rhinitis at given skin wheal size to Artemisia vulgaris (A), Ambrosia artemisifolia (B) and number of skin sensitized allergens (C), derived
from the logistic regression analysis. Fitted predicted probability curves (and 95% CI) for moderate-severe asthma at given skin wheal size to
Dermatophagoides pteronyssinus (D), Dermatophagoides farinae (E) and number of skin sensitized allergens (F), derived from the logistic
regression analysis.
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Figure 2 Serum specific IgE levels and severity of rhinitis.
Distributions in percentage of patients with mild intermittent,
moderate-severe intermittent, mild persistent and moderate-severe
persistent rhinitis by different levels of serum specific IgE.
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rhinitis. Although we did not analyze the data by strati-
fication of the patients with regions and seasons in this
paper, we predict that these patients are mainly from
the northern parts of China undergoing clinical sam-
pling during the season from July to September [12].
One recently published study [11] demonstrated that
sIgE levels to birch- and grass-pollen at baseline as well
as during the pollen season were associated with seaso-
nal symptom severity of rhinitis and use of rescue medi-
cations. In contrast, adult patients with seasonal allergic
rhinitis have been investigated by several studies in this
respect. Some investigators found a positive association
between sIgE levels and clinical symptoms [29,30],
although symptoms were also dependent on other fac-
tors, such as the ease of histamine release by basophils.
Other studies did not find strong associations or
reported inconsistent findings [31,32]. This inconsis-
tency may be explained by differences in allergens, age
or other characteristics of the patient populations stu-
died. At least this seems to be the reason for a marked
variability in the outcome of a variety of studies investi-
gating the capacity to predict symptomatic allergy from
sIgE levels in children [33]. We therefore assume that
some of the above-mentioned differences among studies
in respiratory allergies may be explained by the varying
parameters of the allergens studied, the age of the
patients and the measurements of clinical disease
severity.
Surprisingly, we failed to find the relationship between
HDM skin test size and specific IgE levels and severity of
any type of rhinitis, especially persistent rhinitis, however,
our finding supports the facts that outdoor allergens affect
rhinitis significantly [13,20]. Many studies have shown that
pollen such as Artemisia vulgaris and Ambrosia artemisi-
folia is a larger allergen compared with HDMs and is
mainly deposited in the upper airway where it induces
local inflammatory or pathological changes, whereas enzy-
matic activity of pyroglyphid mites seems to be important
in the pathogenicity of lower airway and systemic inflam-
mations [34,35]. We have extended this observation by
demonstrating the same associations for Chinese weed
grass pollens Artemisia vulgaris and Ambrosia artemisifo-
lia within the group of patients defined as atopic using
standard definitions [17]. These findings also indicate that
IgE-mediated sensitization is not dichotomous in its rela-
tion to the expression, severity and temporal pattern of
upper and lower respiratory allergic diseases.
In this study, we also found by both skin test and sIgE
measurements that patients with sensitizations to multi-
ple allergens were significantly more likely to have more
severe rhinitis and asthma. Our results are in agreement
with the study by Simpson et al. [36]. They investigated a
group of adults with asthma showing that sensitization to
dust mite, cat, dog, and mixed grasses as well as multiple
sensitizations were all independently associated with
asthma. The data of another study [13] suggested that
the development of specific IgE response to multiple
indoor allergens is an important factor in the persistence
of bronchial obstruction in children with asthma.
In summary, the results of the current study empha-
size the importance of sensitization to indoor allergens
in asthma severity and to outdoor allergens in severity
of rhinitis. Sensitization to more than one allergenic
source also significantly increases the possibility of
developing moderate-severe rhinitis and asthma.
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